<?xml version="1.0" encoding="UTF-8"?>
<ref id="B149-pharmaceutics-12-00171">
 <label>149.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Shibata</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>McMullen</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Pham</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Belshan</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Sanford</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Zhou</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Goede</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Date</surname>
    <given-names>A.A.</given-names>
   </name>
   <name>
    <surname>Destache</surname>
    <given-names>C.J.</given-names>
   </name>
  </person-group>
  <article-title>Polymeric Nanoparticles Containing Combination Antiretroviral Drugs for HIV Type 1 Treatment</article-title>
  <source>AIDS Res. Hum. Retrovir.</source>
  <year>2013</year>
  <volume>29</volume>
  <fpage>746</fpage>
  <lpage>754</lpage>
  <pub-id pub-id-type="doi">10.1089/aid.2012.0301</pub-id>
  <?supplied-pmid 23289671?>
  <pub-id pub-id-type="pmid">23289671</pub-id>
 </element-citation>
</ref>
